OWP Pharmaceuticals provides FDA approved epilepsy medications to patients at affordable prices in the United States. We have created a business model that has a significant tie to a “Not for Profit” organization named the ROW Foundation. Through this model both organizations have a vision to drastically improve the lives of epilepsy patients throughout the world including under-resourced patients outside of the United States through increase education, diagnosis and treatment.
Location: United States, Illinois, Naperville
Employees: 11-50
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | His Fund | his.fund |
| - | Visionary ... | visionaryp... |
Mentions in press and media 5
| Date | Title | Description |
| 12.01.2026 | OWP Pharmaceuticals Announces Commercial Product Availability of SUBVENITE® (lamotrigine) Oral Suspension in U.S. Market | LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product availability of SUBVENITE® (lamotrigine) oral suspension in the United States. The U.S. Food and Drug Administration (FD... |
| 17.09.2025 | OWP Pharmaceuticals Announces FDA Approval of SUBVENITE® Oral Suspension | The First and Only Lamotrigine Oral Suspension in the U.S. LISLE, IL, UNITED STATES, September 17, 2025 /EINPresswire.com/ -- OWP Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved SUBVENITE® Oral ... |
| 14.03.2023 | Powering Social Enterprise with Profit and Purpose: The Tandem Hybrid by Scott Boyer, Jeremy Gudauskas, and Mike Hamel | Powering Social Enterprise with Profit and Purpose: The Tandem Hybrid #1 New Release on Amazon in Business Ethics: a detailed blueprint for driving purpose through profit––building a business AND a mission simultaneously. This book makes a ... |
| 30.11.2022 | OWP Pharmaceuticals Announces Patent Application for First Oral Liquid Formulation of Trazodone for Treatment of MDD | OWP has applied for U.S. patent protection for the first-ever oral solution of trazodone, the sixth liquid medication that the company hopes to commercialize. Today we are pleased to have filed a patent application for our unique formulatio... |
| - | OWP Pharmaceuticals | “We envision a world where all people receive the best level of medical and pharmaceutical care regardless of who they are or where they live.” |